A 967079
(Synonyms: (1E,3E)-1-(4-氟苯基)-2-甲基-1-戊烯-3-酮肟) 目录号 : GC11701
A potent inhibitor of the TRPA1 channel
Cas No.:1170613-55-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Animal experiment: | Rats[1]Male Sprague-Dawley rats (250-400 g) are used for all experiments and are housed in a temperature controlled room with a 12/12-hr day/night cycle. Food and water are available ad libitum. Spontaneous and evoked neuronal activity is then measured 5, 15, 25, and 35 min after systemic injection of A-967079 (30 μmol/kg, i.v.) or vehicle (polyethylene glycol). The intravenous injection of A-967079 or vehicle is completed over a 6-7 min period. The i.v. dose of A-967079 is selected based on extrapolated plasma levels that are effective in behavioral studies[1]. |
References: [1]. McGaraughty S, et al. TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats. Mol Pain. 2010 Mar 5;6:14. | |
A-967079 is an antagonist of transient receptor potential A1 (TRPA1) receptor with IC50 values of 289 nM and 67 nM at rat and human TRPA1 receptors, respectively [1].
There is a larger family of transient receptor potential (TRP) ion channels. In this family, there are TRPV, TRPM, TRPC, TRPN, TRPP and TRPML. TRPA1 is a part of this family and is expressed in small and medium-sized peptidergic primary afferent sensory neurons that also express TRPV1 [1].
Treatment with A-967079 attenuated Ca2+ signal in WT TG neurons and resulted in a further reduction in Trpv4-/- TG neurons in response to formalin. Treatment with A-967079 reduced the percentage of responsive cells from 27.7% to 15.8% when acutely blocking TRPA1 and to a mere 3.2% in Trpv4-/- TG neurons plus TRPA1 inhibitor [2].
Spontaneous activity of WDR neurons can indicate central sensitization and possibly non-evoked or ongoing pain. In uninjured and CFA-inflamed rats, systemic injection of A-967079 at 30 μmol/kg, i.v. made responses of wide dynamic range (WDR) and nociceptive specific (NS) neurons decrease, following noxious pinch stimulation of the ipsilateral hind paw. Similarly in both OA and OA-sham rats, A-967079 decreased the responses of WDR neurons to high-intensity mechanical stimulation of the knee joint. Administration with A-967079 also reduced WDR neuronal responses to low-intensity mechanical stimulation (10 g von Frey hair) in CFA-inflamed rats, but not in uninjured rats. Additionally, A-967079 injection decreased the spontaneous activity of WDR neurons in CFA-inflamed rats, but not in uninjured, OA, and OA-sham animals [1].
References:
[1]. McGaraughty S, Chu KL, Perner RJ, et al. TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats. Molecular pain, 2010, 6(1): 1.
[2]. Chen Y, Kanju P, Fang Q, et al. TRPV4 is necessary for trigeminal irritant pain and functions as a cellular formalin receptor. PAIN, 2014, 155(12): 2662-2672.
| Cas No. | 1170613-55-4 | SDF | |
| 别名 | (1E,3E)-1-(4-氟苯基)-2-甲基-1-戊烯-3-酮肟 | ||
| 化学名 | (1Z,3E)-1-(4-fluorophenyl)-2-methylpent-1-en-3-one oxime | ||
| Canonical SMILES | FC1=CC=C(C=C1)/C=C(C)\C(CC)=N\O | ||
| 分子式 | C12H14FNO | 分子量 | 207.24 |
| 溶解度 | DMF: 20 mg/ml,DMSO: 30 mg/ml,DMSO:PBS(pH 7.2) (1:2): 0.3 mg/ml,Ethanol: 20 mg/ml | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 4.8253 mL | 24.1266 mL | 48.2532 mL |
| 5 mM | 0.9651 mL | 4.8253 mL | 9.6506 mL |
| 10 mM | 0.4825 mL | 2.4127 mL | 4.8253 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。